Peptide Based Cardiovascular Therapeutics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

Published on : Aug-2017 | List of Tables : 140 | List of Figures : 42 | No. of Pages : 170 | Report Code : FACT191MR | Format :

Cardiovascular disease is the leading cause of mortality and morbidity all over the world. In the past, the development of peptides as therapeutic agents had been avoided by pharmaceutical industry due to their low stability, rate of degradation and poor delivery. However, in recent times, resurgence has taken place in the field of peptides as therapeutics. Economic factors such as increasing healthcare expenditure and increasing FDI in emerging economies are expected to drive the market of peptide based cardiovascular therapeutics. Additionally, increasing prevalence of cardiovascular disorders, emergence of prominent pharmaceutical and biotech companies and strong R&D in the development of new peptides are fuelling the market growth. However, various factors such as increasing costs of commercialization, rapid metabolism of peptide drugs and regulatory conditions are expected to hamper market growth.

Therapeutic peptides are used in the treatment of cardiovascular disorders that are a leading cause of mortality and morbidity throughout the world. Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. Such type of covalent chemical bonds are formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are differentiated from proteins on the basis of size, and peptides contain 50 amino acids or less approximately.   

This Fact.MR report on the global peptide based cardiovascular therapeutics market forecasts that the global peptide based cardiovascular therapeutics market will touch a value of nearly US$ 1,960 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

Market Taxonomy

Drug

Distribution Channel

Region

Bivalirudin

Hospital Pharmacies

North America

Eptifibatide

Retail Pharmacies

Latin America

 

Online Pharmacies

Europe

 

 

Japan

 

 

APEJ

 

 

MEA

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

For more insights, request sample of this report.

North America Market Set to Dominate the Global Peptide Based Cardiovascular Therapeutics Market in Terms of Revenue

The market in North America is set to dominate the global peptide based cardiovascular therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America peptide based cardiovascular therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.

Bivalirudin Segment Poised to Touch a Value of Nearly US$ 1,360 Mn in 2022

As per the forecast of Fact.MR, the bivalirudin segment is expected to reach a value of nearly US$ 1,360 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Bivalirudin segment is expected to account for more than two-third of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.  

Hospital Pharmacies Segment to exhibit a CAGR of 8.9% During the Assessment Period

As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 960 Mn in the year 2022. This represents a CAGR of 8.9% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global peptide based cardiovascular therapeutics market through 2022, which include AstraZeneca, plc, Corden Pharma GmbH, Ipsen S.A, Merck & Co., Inc., Pfizer Inc, Apotex Holdings, Inc., Dr. Reddy's Laboratories Limited, Fresenius Kabi USA, LLC, Novetide Ltd and Amneal Pharmaceuticals LLC.

Request research methodology of this report.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Global peptide based cardiovascular therapeutics market is exhibiting excellent growth. As the manufacturers are developing new methods for the development of novel peptides that are used in curing of cardiovascular disorders with decreasing cost, this market is showing a positive trajectory. This Fact.MR report analyzes the expansion of global peptide based cardiovascular therapeutics market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

Scope

The scope of Fact.MR’s report is to analyze the global peptide based cardiovascular therapeutics market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Peptide based cardiovascular therapeutics providers, research institutes and key players in the global peptide based cardiovascular therapeutics market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to peptide based cardiovascular therapeutics.

Summary

The report commences with a brief information of the global peptide based cardiovascular therapeutics market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global peptide based cardiovascular therapeutics market.

Overview

The next section offers an overview of the global peptide based cardiovascular therapeutics market. This comprises an introduction to the market, along with a standard definition of the service – peptide based cardiovascular therapeutics. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global peptide based cardiovascular therapeutics market, the report provides updates about market opportunities, which can benefit leading service providers of peptide based cardiovascular therapeutics. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for peptide based cardiovascular therapeutics market players to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of healthcare service providers, and cost structure are provided in this section.

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global peptide based cardiovascular therapeutics market. Drug type, distribution channel and region are key segments that define the growth of the global market for peptide based cardiovascular therapeutics. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.

The report’s last section comprises of the global peptide based cardiovascular therapeutics market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global peptide based cardiovascular therapeutics market.

Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

  • Primary research
  • Secondary research
  • Trade research
  • Focused interviews
  • Social media analysis

1. Global Peptide Based Cardiovascular Therapeutics Market - Executive Summary

2. Global Peptide Based Cardiovascular Therapeutics Market Overview
2.1. Introduction
       2.1.1. Global Peptide Based Cardiovascular Therapeutics Market Taxonomy
       2.1.2. Global Peptide Based Cardiovascular Therapeutics Market Definition
2.2. Global Peptide Based Cardiovascular Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Peptide Based Cardiovascular Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Cardiovascular Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis 
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast By Drug 
3.1. Global Peptide Based Cardiovascular Therapeutics Market Size and Forecast By Drug, 2012-2022
       3.1.1. Bivalirudin Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. Eptifibatide Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region

4. Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast By Distribution Channel 
4.1. Global Peptide Based Cardiovascular Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022
       4.1.1. Hospital Pharmacies Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Retail Pharmacies Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Online Pharmacies Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region

5. Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast By Region
5.1. Global Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       5.1.1. North America Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
                5.1.1.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.2. Latin America Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
                5.1.2.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.3. Europe Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
                5.1.3.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.4. Japan Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
                5.1.4.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.5. APEJ Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
                5.1.5.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.6. MEA Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
                5.1.6.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

6. North America Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast, By Country, 2012-2022
6.1. US Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       6.1.1. Revenue (US$ Mn) Comparison, By Drug 
       6.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
6.2. Canada Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       6.2.1. Revenue (US$ Mn) Comparison, By Drug 
       6.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

7. Latin America Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast, By Country, 2012-2022
7.1. Brazil Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       7.1.1. Revenue (US$ Mn) Comparison, By Drug 
       7.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
7.2. Mexico Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       7.2.1. Revenue (US$ Mn) Comparison, By Drug 
       7.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
7.3. Argentina Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       7.3.1. Revenue (US$ Mn) Comparison, By Drug 
       7.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

8. Europe Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast, By Country, 2012-2022
8.1. Germany Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       8.1.1. Revenue (US$ Mn) Comparison, By Drug 
       8.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.2. UK Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       8.2.1. Revenue (US$ Mn) Comparison, By Drug 
       8.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.3. France Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       8.3.1. Revenue (US$ Mn) Comparison, By Drug 
       8.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.4. Spain Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       8.4.1. Revenue (US$ Mn) Comparison, By Drug 
       8.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.5. Italy Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       8.5.1. Revenue (US$ Mn) Comparison, By Drug 
       8.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.6. Nordic Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       8.6.1. Revenue (US$ Mn) Comparison, By Drug 
       8.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

9. Japan Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast, By Country, 2012-2022
9.1. Japan  Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       9.1.1. Revenue (US$ Mn) Comparison, By Drug 
       9.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

10. APEJ Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast, By Country, 2012-2022
10.1. China Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       10.1.1. Revenue (US$ Mn) Comparison, By Drug 
       10.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.2. India Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       10.2.1. Revenue (US$ Mn) Comparison, By Drug 
       10.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.3. Malaysia Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       10.3.1. Revenue (US$ Mn) Comparison, By Drug 
       10.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.4. Thailand Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       10.4.1. Revenue (US$ Mn) Comparison, By Drug 
       10.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.5. Singapore Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       10.5.1. Revenue (US$ Mn) Comparison, By Drug 
       10.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.6. Australia Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       10.6.1. Revenue (US$ Mn) Comparison, By Drug 
       10.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

11. MEA Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast, By Country, 2012-2022
11.1. GCC Countries Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       11.1.1. Revenue (US$ Mn) Comparison, By Drug 
       11.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
11.2. South Africa Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       11.2.1. Revenue (US$ Mn) Comparison, By Drug 
       11.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
11.3. Nigeria Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       11.3.1. Revenue (US$ Mn) Comparison, By Drug 
       11.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
11.4. Israel Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
       11.4.1. Revenue (US$ Mn) Comparison, By Drug 
       11.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

12. Global Peptide Based Cardiovascular Therapeutics Market Competition Landscape and Company Profile
12.1. Company Share Analysis By Region
12.2. AstraZeneca plc
       12.2.1. Company Overview
       12.2.2. Peptide Based Cardiovascular Therapeutics Market Drug list
       12.2.3. Peptide Based Cardiovascular Therapeutics Market Drug Sales Data and Key Financials
       12.2.4. Key Developments
       12.2.5. SWOT Analysis
12.2. CordenPharma International
       12.2.1. Company Overview
       12.2.2. Peptide Based Cardiovascular Therapeutics Market Drug list
       12.2.3. Peptide Based Cardiovascular Therapeutics Market Drug Sales Data and Key Financials
       12.2.4. Key Developments
       12.2.5. SWOT Analysis
12.3. Ipsen S.A
       12.3.1. Company Overview
       12.3.2. Peptide Based Cardiovascular Therapeutics Market Drug list
       12.3.3. Peptide Based Cardiovascular Therapeutics Market Drug Sales Data and Key Financials
       12.3.4. Key Developments
       12.3.5. SWOT Analysis
12.4. Merck & Co., Inc
       12.4.1. Company Overview
       12.4.2. Peptide Based Cardiovascular Therapeutics Market Drug list
       12.4.3. Peptide Based Cardiovascular Therapeutics Market Drug Sales Data and Key Financials
       12.4.4. Key Developments
       12.4.5. SWOT Analysis
12.5. Pfizer Inc.
       12.5.1. Company Overview
       12.5.2. Peptide Based Cardiovascular Therapeutics Market Drug list
       12.5.3. Peptide Based Cardiovascular Therapeutics Market Drug Sales Data and Key Financials
       12.5.4. Key Developments
       12.5.5. SWOT Analysis
12.6. Apotex Holdings, Inc.
       12.6.1. Company Overview
       12.6.2. Peptide Based Cardiovascular Therapeutics Market Drug list
       12.6.3. Peptide Based Cardiovascular Therapeutics Market Drug Sales Data and Key Financials
       12.6.4. Key Developments
       12.6.5. SWOT Analysis
12.7. Dr. Reddy's Laboratories Limited
       12.7.1. Company Overview
       12.7.2. Peptide Based Cardiovascular Therapeutics Market Drug list
       12.7.3. Peptide Based Cardiovascular Therapeutics Market Drug Sales Data and Key Financials
       12.7.4. Key Developments
       12.7.5. SWOT Analysis
12.8. Fresenius Kabi USA, LLC
       12.8.1. Company Overview
       12.8.2. Peptide Based Cardiovascular Therapeutics Market Drug list
       12.8.3. Peptide Based Cardiovascular Therapeutics Market Drug Sales Data and Key Financials
       12.8.4. Key Developments
       12.8.5. SWOT Analysis
12.9. Novetide Ltd
       12.9.1. Company Overview
       12.9.2. Peptide Based Cardiovascular Therapeutics Market Drug list
       12.9.3. Peptide Based Cardiovascular Therapeutics Market Drug Sales Data and Key Financials
       12.9.4. Key Developments
       12.9.5. SWOT Analysis
12.10. Amneal Pharmaceuticals LLC
       12.10.1. Company Overview
       12.10.2. Peptide Based Cardiovascular Therapeutics Market Drug list
       12.10.3. Peptide Based Cardiovascular Therapeutics Market Drug Sales Data and Key Financials
       12.10.4. Key Developments
       12.10.5. SWOT Analysis

13. Research Methodology

14. Secondary and Primary Sources

15. Assumptions and Acronyms

16. Disclaimer

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Peptide Based Cardiovascular Therapeutics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022